Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking

摘要

In human subjects accustomed to smoking tobacco the withdrawal symptoms associated with the cessation or reduction of tobacco smoking may be prevented by administering to the subject an effective amount of an alpha-2 adrenergic agonist such as clonidine hydrochloride for a suitable period of time. Alternatively, such withdrawal symptoms may be prevented by administering to such a person an effective amount of alprazolam.